Search results for Prezalumab
Prezalumab Biosimilar – Anti-ICOSLG, B7-H2, B7RP-1, CD275 mAb – Research Grade, ProteoGenix, PX-TA1417
Description of Prezalumab Biosimilar - Anti-ICOSLG, B7-H2, B7RP-1, CD275 mAb - Research Grade General information on Anti-ICOSLG/B7-H2/B7RP-1/CD275[Homo sapiens] (Prezalumab) Monoclonal Antibody Prezalumab has been investigated for the treatment of Sjogren’s syndrome Cutaneous Lupus Erythematosus, Psoriasis, and Systemic Lupus Erythematosus (SLE).
Host
Reactivity
Applications
Conjugation
Prezalumab, Abbexa, abx831374
Prezalumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ICOSLG/B7-H2/B7RP-1/CD275, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Research Grade Prezalumab (HF564016), abinScience, HF564016
Host
Human
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Prezalumab Biosimilar - Research Grade, ichor.bio, ICH5214
Detects B7H2
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Please provide the required information below so that we can quickly source your products.